Edgewise Therapeutics, Inc. (EWTX) released Loss for its first quarter that increased from the same period last year and missed the Street estimates.
The company's bottom line came in at -$40.80 million, or -$0.43 per share. This compares with -$39.66 million, or -$0.42 per share, last year.
Analysts on average had expected the company to earn -$0.42 per share. Analysts' estimates typically exclude special items.
Edgewise Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings: -$40.80 Mln. vs. -$39.66 Mln. last year.
-EPS: -$0.43 vs. -$0.42 last year.
For comments and feedback: editorial@rttnews.com